Global /South Korea /Healthcare /Drug Manufacturers - General /001360

SAMSUNG PHARM. Co., LTD.

001360

• KRX: 001360 • Delayed

2,030KRW -3.3%

1.33 USD

As of 13 June 2026, SAMSUNG PHARM. Co., LTD. has a market cap of $129.97M USD, ranking #23779 globally and #1065 in South Korea. It ranks #2137 in the Healthcare sector, and #774 in the Drug Manufacturers - General industry.

Global Rank

23779

Country Rank

1065

Sector Rank

2137

Industry Rank

774

Key Stats

Market Cap

$129.97MUSD

197.65B KRW

Revenue (TTM)

$29.13MUSD

44.29B KRW

Net Income (TTM)

$8.36MUSD

12.71B KRW

Profit Margin

29%

PE Ratio

15.5

PS Ratio

4.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Sung Tag Jung open_in_new

Employees

240

Founded

1929

Website

sspharm.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	-2.9%	8.9%	17%	36%	33%	35%	-27%	-65%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	001360 삼성제약(주) ISIN: KR7001360007 Shares Out.: Shares Outstanding: 94.12M¹ Shares Float: 75.429M² TV: TradingView: KRX: 001360 SA: Stock Analysis: KRX: 001360 YF: Yahoo Finance: 001360.KS GF: Google Finance: KRX: 001360 BA: Barron's: 001360 MS: Morningstar: XKRX: 001360	2,030 KRW	TV: TradingView: KRX: 001360 SA: Stock Analysis: KRX: 001360 YF: Yahoo Finance: 001360.KS GF: Google Finance: KRX: 001360 BA: Barron's: 001360 MS: Morningstar: XKRX: 001360

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as quasi-medicines, cold medicines, vitamins and energy drinks, and functional foods. The company was founded in 1929 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 7K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 5K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 586K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 421K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 277K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 247K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 222K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 211K%	20.5	Switzerland

chevron_leftBack